Publicaciones en las que colabora con MARIA JESUS SANZ FERRANDO (51)

2024

  1. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?

    Pharmacological Research, Vol. 200

2023

  1. Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity

    Pharmacological Research, Vol. 187

  2. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction

    Frontiers in Endocrinology, Vol. 14

  3. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

    Microvascular Research, Vol. 139

  2. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

    Biomedicine and Pharmacotherapy, Vol. 145

2021

  1. Activation of the constitutive androstane receptor inhibits leukocyte adhesiveness to dysfunctional endothelium

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

  2. An updated overview of e-cigarette impact on human health

    Respiratory Research, Vol. 22, Núm. 1

  3. Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients

    Frontiers in Pharmacology, Vol. 12

  4. Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes

    International Journal of Clinical Practice, Vol. 75, Núm. 8

  5. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

  6. Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction

    International Journal of Biochemistry and Cell Biology

  7. Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 131-139

  8. The nuclear retinoid‐related orphan receptor RORα controls adipose tissue inflammation in patients with morbid obesity and diabetes

    International Journal of Obesity, Vol. 45, Núm. 7, pp. 1369-1381

2020

  1. Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways

    Free Radical Biology and Medicine, Vol. 157, pp. 38-54

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: Changes in cytokine/chemokine profile, increased platelet and leukocyte activation

    Journal of Clinical Medicine, Vol. 8, Núm. 1

  3. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARγAgonist Activity and Anti-inflammatory Effect

    Journal of Natural Products, Vol. 82, Núm. 7, pp. 1802-1812

  4. SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 8, pp. 1614-1628

  5. Systemic inflammation in metabolic syndrome: Increased platelet and leukocyte activation, and key role of CX3 CL1/CX3 CR1 and CCL2/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion

    Journal of Clinical Medicine, Vol. 8, Núm. 5